Showing results (561-570 of 583) with videos related to
Sort By:
Pageof 59
Proceedings of the National Academy of Sciences of the United States of America|February 2, 2023
Persistent binding at dopamine transporters determines sustained psychostimulant effectsMarco Niello, Spyridon Sideromenos, Ralph Gradisch, et al.European Journal of Medicinal Chemistry|June 26, 2026
Dual-target mu opioid-dopamine D3 receptor (MOR-D3R) ligands based on etonitazene: New leads for transforming "nitazenes" into novel analgesicsKhorshada Jahan, Grant Glatfelter, Julie Sanchez, et al.Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|October 18, 2012
Powerful cocaine-like actions of 3,4-methylenedioxypyrovalerone (MDPV), a principal constituent of psychoactive 'bath salts' productsMichael H Baumann, John S Partilla, Kurt R Lehner, et al.Journal of Neural Engineering|February 22, 2020
Transcranial photoacoustic imaging of NMDA-evoked focal circuit dynamics in the rat hippocampusJeeun Kang, Shilpa D Kadam, Joshua S Elmore, et al.Molecular Psychiatry|November 5, 2025
The 4-alkyl chain length of 2,5-dimethoxyamphetamines differentially affects in vitro serotonin receptor actions versus in vivo psychedelic-like effectsDino Luethi, Grant C Glatfelter, Eline Pottie, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 18, 2009
Trastuzumab beyond progression in human epidermal growth factor receptor 2-positive advanced breast cancer: a german breast group 26/breast international group 03-05 studyGunter von Minckwitz, Andreas du Bois, Marcus Schmidt, et al.ACS Pharmacology & Translational Science|November 21, 2022
Structure-Activity Relationships for Psilocybin, Baeocystin, Aeruginascin, and Related Analogues to Produce Pharmacological Effects in MiceGrant C Glatfelter, Eline Pottie, John S Partilla, et al.European Journal of Cancer (Oxford, England : 1990)|July 12, 2011
Trastuzumab beyond progression: overall survival analysis of the GBG 26/BIG 3-05 phase III study in HER2-positive breast cancerGunter von Minckwitz, Kathrin Schwedler, Marcus Schmidt, et al.Drug and Alcohol Dependence|June 7, 2026
Pharmacokinetics of xylazine and fentanyl in patients presenting to the emergency department after non-fatal opioid overdoseAlex J Krotulski, Michael H Baumann, Brittany P Chapman, et al.Frontiers in Digital Health|August 5, 2025
Effectiveness of mHealth interventions targeting physical activity, sedentary behaviour, sleep or nutrition on emotional, behavioural and eating disorders in adolescents: a systematic review and meta-analysisH Baumann, B Singh, A E Staiano, et al.Pageof 59